ESC Professional Premium Access

A novel strategy for key gene identification in hypertrophic cardiomyopathy based on cuproptosis and multiple WGCNA analyses

Congress Presentation

About the speaker

Doctor Yichao Xiao

The Second Xiangya Hospital of Central South University, Changsha (China)
1 presentation
0 follower

6 more presentations in this session

The Australian Genetic Heart Disease Registry: Insights into healthcare utilisation and outcomes for genetic heart disease

Speaker: Ms A. Butters (Sydney, AU)


Family screening in hypertrophic cardiomyopathy - clinical and genetic yield at baseline

Speaker: Doctor E. Silajdzija (Copenhagen, DK)


Clinical significance and genetic basis of hypertrophic cardiomyopathy with apical phenotype: comparison of pure-apical form and distal-dominant form

Speaker: Doctor K. Sugiura (Nankoku, JP)


Epigenetic study of the differential phenotypic expression of a hypertrophic cardiomyopathy-related pathological variant at MYBPC3 in a cohort of monozygotic twins

Speaker: Mr A. Penarroya (Oviedo, ES)


Founder effect of a pathogenic TNNT2 variant in the northwest of Spain responsible for a non-severe phenotype of hypertrophic cardiomyopathy.

Speaker: Doctor M. Valverde (Coruna, A, ES)


Access the full session

Hypertrophic cardiomyopathy: genotypes and phenotypes

Speakers: Doctor Y. Xiao, Ms A. Butters, Doctor E. Silajdzija, Doctor K. Sugiura, Mr A. Penarroya...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by